Clomiphene Citrate vs Enclomiphene
A side-by-side research comparison of Clomiphene Citrate and Enclomiphene across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Clomiphene Citrate | Enclomiphene |
|---|---|---|
| Full name | Clomiphene Citrate (Clomid) | Enclomiphene Citrate |
| Category | Hormone Replacement | Hormone Replacement |
| Status | FDA Approved (off-label for men) | Investigational drug |
| Mechanism | Blocks estrogen receptors in the hypothalamus, preventing negative feedback. This increases GnRH pulsatility, elevating pituitary LH and FSH output and subsequently testicular testosterone production. | Blocks estrogen receptors in the hypothalamus, reducing negative feedback and increasing GnRH pulsatility, which stimulates LH and FSH release for endogenous testosterone production. |
| Molecular weight | 598.09 Da (citrate salt) | 598.09 Da |
| Half-life | ~5-7 days | 10-14 hours |
| Bioavailability | ~80% oral | ~50% oral |
| Typical dose | 12.5-50 mg | 12.5-25 mg |
| Frequency | Daily or every other day | Daily |
| Route | Oral | Oral capsule |
Clomiphene Citrate reported benefits
- Increased endogenous testosterone
- Preserved fertility
- Elevated LH/FSH
- No testicular atrophy
- Improved sperm parameters
Enclomiphene reported benefits
- Increased endogenous testosterone
- Preserved fertility
- Improved libido
- Enhanced energy and mood
- No testicular atrophy
Related comparisons
Research and educational reference only. Not medical advice.